Olympus Corporation (TYO: 7733)

Market Cap	2.68T
Revenue (ttm)	973.60B
Net Income (ttm)	75.25B
Shares Out	1.13B
EPS (ttm)	64.05
PE Ratio	31.82
Forward PE	21.16
Dividend	20.00 (0.85%)
Ex-Dividend Date	Mar 28, 2025

Volume	4,392,300
Open	2,372.00
Previous Close	2,344.00
Day's Range	2,366.00 - 2,400.50
52-Week Range	1,935.50 - 2,867.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Olympus

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1919
• Employees: 28,838
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7733

Financial Performance

In 2023, Olympus's revenue was 936.21 billion, an increase of 6.16% compared to the previous year's 881.92 billion. Earnings were 242.57 billion, an increase of 69.12%.